Seguridad de la asociación de aspirina, clopidogrel y acenocumarol en pacientes con indicación de anticoagulación

Observance of Antiplatelet Therapy after Stent Implantation in Patients under Chronic Oral Anticoagulant Treatment

“…The high incidence of adverse events recorded in our series is also noteworthy with its overall mortality of 12.8% and a global incidence of hemorrhages of 20% and major bleeding in 8.6%, also similar to that described in previous papers. 9,10 The high-risk clinical profile of the population under study means that the medium-and long-term prognosis for this kind of patient is markedly worse than that of an unselected population treated with coronary stents.…”